BridgeBio Pharma, Inc. (BBIO)
68.15
+0.01
(+0.01%)
USD |
NASDAQ |
Feb 23, 11:44
BridgeBio Pharma Market Cap : 13.06B for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 34.39B |
| Mirum Pharmaceuticals, Inc. | 5.435B |
| Cogent Biosciences, Inc. | 5.681B |
| Alnylam Pharmaceuticals, Inc. | 43.88B |
| Sarepta Therapeutics, Inc. | 1.915B |
Market Cap Related Metrics
| PS Ratio | 36.69 |
| PEG Ratio | -0.2212 |
| Price | 68.15 |
| Earnings Yield | -6.14% |
| PEGY Ratio | -0.2212 |